On October 15, 2026, Injective CEO Eric Chen, accompanied by the company's general counsel, head of policy, and head of research, met with officials from the White House, the U.S. Securities and Exchange Commission (SEC), and the Commodity Futures Trading Commission (CFTC) in Washington, D.C. (one source places the meeting on October 14).